Sang-Cheol Han
Fortune : 10 M $ au 31/08/2026
Fortune : 10 M $ au 31/08/2026
Sang-Cheol Han currently works at JEIL PHARMA HOLDINGS, Inc., as President, CEO & Executive Director, Jeil Pharmaceutical Co., Ltd., as Co-President & Co-Chief Executive Officer from 2025, and Jeil Health Science, Inc., as Chief Executive Officer.
Mr. Han received his Masters Business Admin degree from Rochester Christian University.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 15/07/2026 | 1 699 302 ( 10,64% ) | 9 M $ | 31/08/2026 | |
| 30/06/2026 | 90 229 ( 0,61% ) | 704 110 $ | 31/08/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| JEIL PHARMA HOLDINGS INC | Directeur Général | 02/06/2017 |
| JEIL PHARMACEUTICAL CO.,LTD | Directeur Général | 25/03/2025 |
Jeil Health Science, Inc.
Jeil Health Science, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Directeur Général | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 4 |
|---|---|
Rochester Christian University
Rochester Christian University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
JEIL PHARMA HOLDINGS, Inc.
JEIL PHARMA HOLDINGS, Inc. Pharmaceuticals: MajorHealth Technology Engages in the manufacture and sale of pharmaceutical products | Health Technology |
Jeil Pharmaceutical Co., Ltd.
Jeil Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
Jeil Health Science, Inc.
Jeil Health Science, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national